Dependence vs Addiction: What Is the Difference?

Why the distinction matters clinically

The terms dependence and addiction are often used interchangeably in everyday conversation, and that imprecision causes real problems. A person who has been prescribed opioid pain medication long-term and has developed physical dependence, meaning their body now requires the medication to avoid withdrawal, may not have an addiction at all. Meanwhile, a person who uses alcohol episodically but finds it impossible to stop despite destroyed relationships and lost employment has addiction, even if their physical withdrawal symptoms are mild.

Treating these two situations as identical leads to poor clinical decisions. A patient being tapered off a benzodiazepine under medical supervision is managing physical dependence: the treatment is a slow, controlled reduction. A person whose compulsive substance use is driving escalating harm needs addiction treatment: therapy, behavioral change, and in many cases medication-assisted treatment for a longer-term course.

The DSM-5, the diagnostic manual used by clinicians across the United States, addressed this confusion directly by replacing earlier categorical language with the term Substance Use Disorder (SUD) and grading severity by the number of diagnostic criteria met, from mild to severe. Understanding where dependence fits within that framework is the starting point for an accurate conversation about what kind of help someone needs.

Physical dependence: what it is and what it is not

Physical dependence is a physiological state in which the body has adapted to the presence of a substance so that removing it produces withdrawal symptoms. It develops through a mechanism called neuroadaptation: the central nervous system, in response to repeated exposure, adjusts its baseline functioning to accommodate the drug. When the drug is removed, those adaptations produce the opposite effects.

For opioids, neuroadaptation means the brain down-regulates its own endorphin production and reduces the sensitivity of opioid receptors. When the opioid is removed, the person experiences muscle aches, nausea, sweating, anxiety, and intense discomfort because the brain is suddenly undersupplied with the signaling it had come to rely on. For benzodiazepines and alcohol, neuroadaptation involves the GABA system, and withdrawal can produce seizures and, in severe cases, life-threatening complications.

Physical dependence is not unique to drugs of abuse. A patient who has taken corticosteroids for a medical condition and needs to taper off will experience adrenal insufficiency if they stop abruptly. A person who has taken antidepressants long-term may experience discontinuation syndrome when they stop. These are examples of physical dependence without any element of addiction or substance use disorder. The presence of withdrawal symptoms upon stopping a substance does not, by itself, constitute addiction.

• Tolerance: the body requires progressively more of a substance to produce the same effect, as receptors become less sensitive
• Withdrawal: a predictable set of physical symptoms when the substance is reduced or stopped, driven by neuroadaptation
• Neither tolerance nor withdrawal alone meets the diagnostic criteria for Substance Use Disorder under the DSM-5
• Physical dependence can develop with many prescribed medications including opioids, benzodiazepines, beta-blockers, SSRIs, and corticosteroids

Addiction: the DSM-5 definition of Substance Use Disorder

Addiction, in current clinical terminology, is a Substance Use Disorder (SUD). The DSM-5 defines SUD as a problematic pattern of substance use leading to clinically significant impairment or distress, with at least two of eleven criteria present within a twelve-month period. Severity is rated on a spectrum: mild (two to three criteria), moderate (four to five criteria), or severe (six or more criteria).

The eleven diagnostic criteria span four domains. The first domain covers impaired control: taking the substance in larger amounts or for longer than intended, a persistent desire or unsuccessful efforts to cut down or control use, spending a great deal of time obtaining or using the substance or recovering from its effects, and craving or a strong desire to use the substance. The second domain covers social impairment: failure to fulfill major role obligations, continued use despite persistent social or interpersonal problems caused by use, and giving up important activities because of use. The third domain covers risky use: using in situations where it is physically hazardous, and continuing use despite knowing about a persistent physical or psychological problem caused or worsened by the substance. The fourth domain covers pharmacological criteria: tolerance and withdrawal.

This framework captures the core of what distinguishes addiction from dependence. The defining features of addiction are compulsive use that continues despite significant negative consequences, loss of control over the substance, and the subordination of other life priorities to the substance. Tolerance and withdrawal are included as two of the eleven criteria but are not sufficient alone to meet the threshold for even mild SUD.

Importantly, the DSM-5 notes that tolerance and withdrawal occurring solely as a result of prescribed medical treatment do not count toward the SUD criteria when being used as directed. A cancer patient who develops tolerance to prescribed opioids during palliative care is not by definition developing a substance use disorder. The clinical picture, the pattern of use, the presence of loss of control, and the functional consequences matter as much as the pharmacological markers.

Examples where the distinction matters

The clinical importance of distinguishing dependence from addiction becomes clear in a few common scenarios that clinicians in Monmouth County and across New Jersey encounter regularly.

A person who was prescribed opioids after back surgery and has been taking them as directed for six months now needs to stop. They are not seeking extra doses, not obtaining prescriptions from multiple providers, not experiencing functional decline due to the opioids. They have physical dependence and require a medically supervised taper. They do not have an opioid use disorder. Treatment is a structured reduction, not an addiction program.

A person who was also prescribed opioids after surgery but has since escalated their dose beyond the prescription, is seeking pills from family members' medicine cabinets, has lost a job due to impairment, and continues to use despite knowing it is harming their health and relationships has opioid use disorder. The physical dependence is present too, but it is the compulsive pattern, the loss of control, and the continued use despite consequences that define the addiction.

Someone who uses alcohol heavily on weekends and is not physically dependent because they do not drink daily may still have Alcohol Use Disorder if the pattern involves failed attempts to stop, driving while impaired, and significant relationship damage caused by the use. Severity of addiction does not require physical dependence.

Why compulsive use is the defining feature of addiction

Among all the DSM-5 criteria, the ones that most distinctively characterize addiction as opposed to simple physical dependence are those involving compulsive use despite consequences, loss of control, and craving. These reflect changes in the brain circuitry governing motivation, impulse control, and reward that go beyond physical adaptation.

The prefrontal cortex, responsible for planning, decision-making, and impulse control, becomes dysregulated by chronic substance use in a way that physical dependence alone does not explain. The brain's motivational system shifts so that obtaining and using the substance becomes a higher priority than food, relationships, and self-preservation. This is why a person with severe SUD will continue to use despite knowing, intellectually and with complete clarity, that the substance is destroying their life. The knowing is present; the control is not. Physical dependence explains withdrawal. Addiction explains why someone uses even when they desperately want to stop.

This distinction informs treatment design. Managing physical dependence requires medically supervised withdrawal, potentially medication-assisted taper, and in some cases medication maintenance. Treating addiction additionally requires behavioral therapy, motivational work, relapse-prevention skill-building, co-occurring mental health treatment, and often longer-term medication-assisted treatment for opioid use disorder. The two categories require overlapping but distinct interventions.

How The Archangel Centers applies this clinically

At Archangel Behavioral Health in Tinton Falls, every client who enters treatment receives a comprehensive clinical assessment using the ASAM Criteria framework. That assessment evaluates the full picture: current physical state including withdrawal risk, substance use history and pattern, co-occurring mental health conditions, motivation, relapse history, and home environment. It does not assume that the presence of physical dependence equals addiction, and it does not assume that the absence of dramatic withdrawal symptoms means addiction is absent.

The distinction between dependence and addiction shapes the treatment plan. A client with opioid use disorder who has physical dependence is assessed for whether medical detox is needed before outpatient programming can begin, and the clinical team coordinates with accredited detox partners to manage that step. A client with alcohol use disorder is screened for the severity of withdrawal risk, because alcohol and benzodiazepine withdrawal can be medically dangerous and must be managed appropriately.

The behavioral therapy, group work, and relapse-prevention planning that define our PHP and IOP programs address the addiction, the compulsive pattern, the loss of control, the co-occurring factors that drive use. Medication-assisted treatment for opioid use disorder addresses both the physical and neurological components. The clinical team keeps both layers in view throughout treatment.